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Abstract We cloned the Saccharomyces cerevisiae homologue
of mammalian RNase HI, which itself is related to the
prokaryotic RNase HII, an enzyme of unknown function and
previously described as having minor activity in Escherichia coli.
Expression of the corresponding yeast 35 kDa protein (named by
us RNase H(35)) in E. coli and immunological analysis proves a
close evolutionary relationship to mammalian RNase HI.
Deletion of the gene (called RNH35) from the yeast genome
leads to an about 75% decrease of RNase H activity in
preparations from the mutated, still viable cells. Sequence
comparison discriminates this new yeast RNase H from earlier
described yeast enzymes, RNase H(70) and RNase HI.
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1. Introduction
Since the availability of the complete sequence of the Sac-
charomyces cerevisiae genome [1] it has been convenient to
search for genes related to those known from other organisms.
Using the well developed genetics of the budding yeast, S.
cerevisiae, functional information can in many cases be ob-
tained more easily than from studies with a complex organism
from which a certain gene was originally cloned.
We have been studying ribonucleases H (RNases H), en-
zymes which speci¢cally hydrolyze the RNA moiety of RNA-
DNA hybrids, from di¡erent organisms [2^6], and recently
cloned the large, enzymatically active subunit of human
RNase HI (Frank et al., in preparation). In mammalia,
RNase HI is the major RNase H activity and probably plays
a role during DNA replication [7,8]. Earlier we had charac-
terized a RNase H from budding yeast (RNase H(70), see [2]),
and now asked ourselves whether this enzyme might be the
homologue of the large subunit of human RNase HI.
Although this was not the case, a new RNase H from yeast
which we have named RNase H(35) was found; this enzyme
does indeed represent the homologue of human RNase HI,
and in addition, is related to the prokaryotic RNase HII. Here
we will describe the cloning of the gene, RNH35, the partial
puri¢cation of the protein and the reduced RNase H activity
of a deletion mutant.
2. Materials and methods
2.1. Yeast strains and growth media
Strain K699a (Mata ura3 ade2-1 trp1-1 can1-100 leu2-3,112 his3-
1,15 ssdl) was originally supplied by K. Nasmyth, strain BFRH35a
(Mata rnh35v : :HIS3 ura3 ade2-1 trp1-1 can1-100 leu2-3,112 his3-
1,15 ssdl) was constructed in the course of this study. YPD growth
medium (1% yeast extract, 2% peptone, 2% dextrose) was used as a
standard medium, synthetic complete medium was prepared as de-
scribed by Sherman [9].
2.2. PCR ampli¢cation and cloning procedures
Using the recently sequenced gene for the large subunit of human
RNase HI (Frank et al., in preparation) for screening for a homolo-
gous gene in the yeast genome, ORF YNL072w on chromosome XIV
turned out to be the best candidate. In order to amplify YNL072w for
cloning into an expression vector, PCRs were performed with genomic
yeast DNA (Promega) as a template. The following primers were used
for PCR with the Expand PCR system (Boehringer Mannheim): cty1/
BglII, which covers the 5P end of the ORF, including the ATG start
codon (underlined), and introduces a BglII site (bold): 5P-GAT-
GTCGAGATCTATGGTACCCCCCACGGTAGAAGCATC-3P, and
cty3/SalI, which covers the 3P end of the ORF and introduces a SalI
site (bold): 5P-GATGTCGTCGACATATAGTATGTGCAAACTG-
GAGGTGATCACCGG-3P. A PCR product of 975 bp in size was
obtained, digested with BglII and SalI, gel puri¢ed and ligated into
a BglII/SalI digested pXa1 expression vector (Merck). This vector
system allows the expression of L-galactosidase fusion proteins after
induction with IPTG. The ligation sample was transformed into com-
petent XL1 Blue Escherichia coli cells. Bacterial cultures were grown
in the presence of IPTG and harvested by centrifugation. Bacterial
pellets were processed for SDS-PAGE and analyzed on 8.5% gels for
the presence of a fusion protein of the correct size (160 kDa).
For the production of a deletion allele of the YNL072w gene, the
following primers were used for generating a 1650 bp fragment to be
cloned into pUC18: cty3d/EcoRI: 5P-TGTGACTGAATTCGGC-
TGTGTGGATGATGTAAACAGGCAG-3P, and cty4d/HindIII: 5P-
CGGATGTAAGCTTCCGGGAGACAATTGGTCACCTTCCTTC-
3P. A PCR product of the expected size was obtained, digested with
EcoRI and HindIII, gel puri¢ed and ligated into EcoRI/HindIII of the
pUC18 vector. A fragment of 910 bp including nearly the complete
ORF was replaced by a 1890 bp fragment carrying the HIS3 gene.
The isolated and gel puri¢ed deletion allele was used for integrative
transformation [10], and His transformants were isolated. They were
checked by speci¢c PCR for successful gene replacement and analyzed
for RNase H activity. One of the mutants, BFRH35a, was used for
further experiments.
2.3. Expression, puri¢cation and factor Xa digestion of the
YNL072w-L galactosidase fusion protein
Recombinant fusion protein from the pXa1 expression plasmid was
puri¢ed as follows: 100 ml of a bacterial overnight culture was grown
in Luria broth in the presence of 1 mM IPTG and 25 Wg/ml ampicil-
lin. The cells were harvested by centrifugation and opened by ultra-
sonic treatment in ice-cold bu¡er A (PBS+5 mM EDTA). Then the
extract was treated with benzonase (Merck) to destroy RNA and
DNA and 8 M urea to solubilize inclusion bodies. The preparation
was loaded onto a BioRad 691 prepcell (preparative gel electropho-
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resis) and separated on a cylindrical 4% gel. Elution fractions were
analyzed for the presence of puri¢ed fusion protein by analytical 8.5%
SDS-PAGE. Fractions containing the fusion protein were pooled and
dialyzed three times against bu¡er A. Then they were concentrated in
the dialysis bag by external treatment with aquacide II (Calbiochem).
The concentrated fraction was digested with factor Xa protease at
room temperature for di¡erent time periods. The e⁄ciency of the
digestion was analyzed by 12% SDS-PAGE.
2.4. Enzyme activity assay and standard techniques for protein analysis
RNase H assays were performed as described earlier [2]. Protein
concentration was determined by the method of Bradford [11]. Dis-
continuous SDS-PAGE was performed according to Laemmli [12],
and protein bands were visualized with Coomassie brilliant blue
G250 or by silver staining [13]. Western blotting was performed as
described earlier [14] using an antiserum raised against puri¢ed calf
thymus RNase HI [15].
2.5. Enrichment of total RNase H activity from yeast cell extract
To minimize proteolysis, all puri¢cation steps were carried out at
4‡C, and protease inhibitors (0.2 mM PMSF and 1 mM sodium sul-
¢te, pH 8.0; 0.1 mM sodium tetrathionate; 1 WM each of NK-p-tosyl-
L-lysine-chloromethylketone, N-tosyl-L-phenylalanine-chloromethylke-
tone, pepstatin A, and antipain) and 0.1% L-mercaptoethanol were
included in all bu¡ers. The strain in question was grown to mid-log
phase, harvested by centrifugation, washed once with bu¡er B (20
mM Tris-HCl pH 7.9, 1 mM EDTA, 10% glycerol) containing 2 M
NaCl, and frozen in liquid nitrogen. The cell pellet (10 g wet weight)
was resuspended in 17 ml of bu¡er B containing 2 M NaCl, and after
addition of an equal volume of acid washed glass beads (diameter 0.45
mm), the suspension was homogenized and separated from the glass
beads, undisrupted cells and cell fragments as described [2]. The cell
extract was subsequently centrifuged for 100 min at 50 000 rpm in a
Beckman 55.2 Ti rotor. To remove nucleic acids, the supernatant was
treated with polyethylene glycol 6000 (10% w/v ¢nal concentration)
for 30 min on ice followed by centrifugation for 35 min at 22 000 rpm
(Beckman 55.2 Ti rotor). After dialysis of the supernatant against
bu¡er B containing 0.1 M NaCl and centrifugation of the dialysate
for 25 min at 24 000 rpm (Beckman 55.2 Ti rotor), the clear super-
natant was chromatographed on a 40 ml DNA-cellulose column as
described earlier [2]. The bound protein was completely eluted with
bu¡er B containing 2 M NaCl. Protein containing fractions were
pooled and analyzed for RNase H activity.
3. Results
3.1. The open reading frame YNL072w of the S. cerevisiae
genome codes for a RNase H
When searching the budding yeast genome for homologies
with the sequence of the enzymatically active subunit of hu-
man RNase HI (Frank et al., in preparation) we found ORF
YNL072w on chromosome XIV, which encodes a hypothet-
ical protein of 34.9 kDa. The overall identity between the 307
aa yeast sequence and the 299 aa human sequence is 36.6%,
and therefore we considered it a reasonable assumption that
we had discovered a yeast gene for a RNase H. Interestingly,
this gene is also related to gene rnhb from E. coli (Fig. 1)
which was earlier found to encode a so-called minor RNase
H activity, named RNase HII [16]. Further searching revealed
the presence of related, but biochemically and genetically un-
characterized sequences in many of the eubacterial, archae-
bacterial and eukaryotic organisms as we report elsewhere
(Frank et al., in preparation), and as others have noticed
[17,18] while this manuscript was in preparation. Fig. 1 shows
that, if the three sequences with experimentally proven RNase
H identity, the yeast, human, and E. coli RNase H, are com-
pared, the overall identities are limited, nevertheless there exist
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Fig. 1. Overall sequence alignment of the yeast ORF YNL072w (marked S.c., EMBL accession number Z71348), the large subunit of human
RNase HI (marked H.s., EMBL accession number Z97029) and the E. coli RNase HII (marked E.c., SwissProt accession number P10442) [16].
The alignment was generated using the ‘Multiple sequence alignment with hierarchical clustering method’ of Corpet [28], and manually modi¢ed
as follows: amino acids identical in all three sequences are marked in bold letters, similar amino acids are underlined. In the consensus se-
quence (tcon.), bold letters indicate identical amino acids, and asterisks similar amino acids. Parameters used for the alignment: symbol com-
parison table: blosum62; gap weight: 12; gap length weight: 2. In addition, identities between the two eukaryotic sequences are marked as #
in the line (econ.) above the alignment.
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¢ve regions of pronounced homology, indicated by numbers
I^V in Fig. 1.
3.2. Expressing the S. cerevisiae 34.9 kDa ORF in E. coli
yields a protein immunologically closely related to
mammalian RNase HI
In order to examine the immunological relationship of the
yeast ORF YNL072w with mammalian RNase HI, we ex-
pressed it in E. coli. Using PCR primers with appropriate
cloning sites at both ends, we ampli¢ed the corresponding
DNA fragment from genomic yeast DNA (Promega) and
cloned it into the E. coli expression vector pXa1, as described
in Section 2. There it was expressed as a fusion protein with L-
galactosidase. Puri¢cation of the fusion protein and cleavage
with the protease factor Xa led to the expected 34.9 kDa
protein. As shown in Fig. 2, this protein is speci¢cally recog-
nized by the antibody against calf thymus RNase HI in West-
ern blot analysis. Therefore we named the ORF YNL072w
RNH35, and its protein product RNase H(35).
3.3. Deletion of the gene RNH35 from the genome of S.
cerevisiae results in a decrease of total RNase H activity
Using integrative transformation [10] with the deletion con-
struct, described in Section 2, we obtained the viable haploid
strain BFRH35a. A cell extract of this strain exhibited a 50%
decrease in overall RNase H activity compared to an extract
from the corresponding RNase H(35) pro¢cient strain (data
not shown). RNase H activity was enriched from cell extracts
of both strains by removal of nucleic acids and DNA cellulose
chromatography (see Section 2), and the resulting fractions
were tested for RNase H activity using Mg2 as divalent cat-
ion. As shown in Fig. 3, RNase H activity of the fraction
derived from the deletion mutant is about 75% lower than
that derived from the strain with the intact RNH35 gene.
Thus, RNase H(35) obviously is the main RNase H activity
of the unicellular eukaryote S. cerevisiae, a ¢nding in agree-
ment with its homology to RNase HI, which in mammals also
represents the major RNase H active enzyme.
4. Discussion
Although ribonuclease H activity had been discovered in
eukaryotic tissue [19] before it was detected in a retroviral
reverse transcriptase [20], and before a RNase H was puri¢ed
from the bacterium E. coli [21,22], the biological roles of
eukaryotic RNases H are still elusive. Intuitively, removal of
RNA primers from Okazaki fragments during lagging strand
DNA synthesis is the function ascribed to cellular enzymes
exhibiting RNase H activity (see however [23]). In E. coli
this task is mainly carried out by DNA polymerase I [24]
and the extensively studied RNase HI of this organism has
a di¡erent function in the replication of the bacterial genome:
it eliminates RNA transcripts, which may accidentally hybrid-
ize to the template, in order to prevent initiation of DNA
replication at sites other than oriC, the canonical replication
origin of the E. coli genome (for review see [25]). Unfortu-
nately, the biological role of the second RNase H of E. coli,
called RNase HII [16], which is the homologue of the large,
enzymatically active subunit of the major human RNase H,
called RNase HI (Frank et al., in preparation), and of the
yeast enzyme described in this communication, is unknown.
The gene encoding a hitherto unknown budding yeast
RNase H was found by screening the database of the total
S. cerevisiae genome with the complete sequence of the cDNA
of human RNase HI, large subunit. The ORF YNL072w,
situated on the left arm of S. cerevisiae chromosome XIV
(between genes MSK1 and LAT1), was found to encode a
protein very similar to the human enzyme (Fig. 1) in sequence,
size (around 35 kDa) and recognition by an antiserum against
the bovine RNase HI (Fig. 2). The following criteria con-
vinced us that gene YNL072w does indeed encode a RNase
H: (i) expression in and puri¢cation from E. coli resulted in a
protein which is strongly recognized by an antibody, raised
against puri¢ed calf thymus RNase HI, and (ii) a yeast strain
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Fig. 2. Expression of the of yeast RNase H(35) in E. coli. Puri¢ed
yeast RNase H(35)-L-galactosidase fusion protein (lane 1) was di-
gested with factor Xa for 0 min (lane 2), 90 min (lane 3) and 120
min (lane 4) and analyzed on a 12% gel. A: Silver staining. B:
Western blotting with anti-calf thymus RNase HI antibody. Posi-
tions of protein Mr markers are indicated.
Fig. 3. Deletion of gene RNH35 from the yeast genome causes a de-
crease in RNase H activity. A wild-type strain (F) and a strain har-
boring the deletion allele, rnh35v : :HIS3 (R) were used for the
preparation of DNA cellulose fractions enriched in RNase H activ-
ity (see Section 2), and assayed for RNase H activity (103 cpm cor-
responds to 22.2 nmol ribonucleotides released).
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from whose genome gene YNL072w was deleted showed a
signi¢cant decrease in total RNase H activity (Fig. 3). There-
fore we renamed the gene RNH35 and its product RNase
H(35).
The fact that a haploid yeast strain completely missing gene
RNH35 is alive and does not show any serious phenotype
under usual laboratory conditions may indicate that yeast
possesses other enzymes which may substitute for RNase
H(35), or that the newly discovered enzyme is essential under
living conditions which may occur in nature and may be very
di¡erent from the nutritionally rich environment of the labo-
ratory. The behavior of the deletion mutant under various
more specialized conditions, like starvation or other kinds of
stress, remains to be investigated. Regarding other RNases H
of yeast, the biological role of all of which is unknown, we
refer to earlier studies of several laboratories (for review see
[26]) but we have no information on whether any of these
previously described enzymes may be identical to RNase
H(35). As far as S. cerevisiae gene RNH1 [27] is concerned,
and yeast RNase H(70) which was discovered in our own
laboratory [2], we know for certain that this is not the case
(Frank et al., in preparation). The evolutionary conservation
suggests that the RNase H family, of which RNase H(35) is a
member, plays an important role in all living cells for manag-
ing the metabolism of RNA-DNA hybrids.
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